IMMUNE ANEMIAS AND THROMBOCYTOPENIAS IN NON-HODGKIN'S LYMPHOMA

Non-Hodgkin lymphomas (NHL) are the most common hematological malignancies, the incidence of which has shown a significant increase in rates over the year, worldwide, as well as in the Republic of Moldova. [1] The association of immune complications in patients with NHL is common, which can be appreciated shortly before or during the manifestation of the malignant lymphoma. [2, 3] On the basis of a database of 64 NHLs patients registered at the Oncological Institute, Chisinau, Republic of Moldova, a study was done to examine the clinical, and evolutionary particularities of immune anemias and thrombocytopenias in NHL. Immune hemolytic anemia (IHA) and immune thrombocytopenia (IT) are the most common immune complications and are more commonly in indolent NHL, advanced stages, nodal and spleen NHL onset, female gender. NHLs were most frequently associated with an immune comorbidity, and much less often concomitant immune comorbidities were appreciat